XOLAIR
Live / Registered — Registered — international registration renewed (as of 27 Jun 2025)
What this means for you
Registered since 04 Jun 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79250397
- Registration number
- 5766518
- Mark type
- Stylized text
- Filed
- 30 Oct 2018
- Published for opposition
- 19 Mar 2019
- Registered
- 04 Jun 2019
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of severe allergic reactions following exposure to an allergen
Owner
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 27 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 27 Jun 2025 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 26 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Mar 2025 — TEAS SECTION 71 & 15 RECEIVED
- 16 Aug 2019 — NOTIFICATION PROCESSED BY IB
- 30 Jul 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 30 Jul 2019 — FINAL DISPOSITION PROCESSED
- 04 Jul 2019 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 04 Jun 2019 — REGISTERED-PRINCIPAL REGISTER
- 19 Mar 2019 — PUBLISHED FOR OPPOSITION
- 27 Feb 2019 — NOTICE OF PUBLICATION
- 05 Feb 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Feb 2019 — ASSIGNED TO EXAMINER
- 02 Feb 2019 — APPLICATION FILING RECEIPT MAILED
- 29 Jan 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED